NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE50135 Query DataSets for GSE50135
Status Public on Dec 22, 2013
Title A novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-kB signaling in chordoma biology [expression array]
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Chordoma is a rare primary bone malignancy that arises in the skull base, spine and sacrum and originates from remnants of the notochord. These tumors are typically resistant to conventional chemotherapy, and to date there are no FDA-approved agents to treat chordoma. The lack of in vivo models of chordoma has impeded the development of new therapies for this tumor. Primary tumor from a sacral chordoma was xenografted into NOD/SCID/IL-2R γ-null mice. The xenograft is serially transplantable and was characterized by both gene expression analysis and whole genome SNP genotyping. The NIH Chemical Genomics Center performed high-throughput screening of 2,816 compounds using two established chordoma cell lines, U-CH1 and U-CH2B. The screen yielded several compounds that showed activity and two, sunitinib and bortezomib, were tested in the xenograft. Both agents slowed the growth of the xenograft tumor. Sensitivity to an inhibitor of IκB, as well as inhibition of an NF-κB gene expression signature demonstrated the importance of NF-κB signaling for chordoma growth. This serially transplantable chordoma xenograft is thus a practical model to study chordomas and perform in vivo preclinical drug testing.
 
Overall design Total five microarray experiments were conducted, two of which are for chordoma xenograft sammples and three for chrodoma primary tumor. RNA extracted from xenograft samples and from chordomas was hybridized to Illumina arrays.
 
Contributor(s) Meltzer P, Loeb D
Citation(s) 24223206
Submission date Aug 22, 2013
Last update date Apr 09, 2014
Contact name Yuelin Jack Zhu
E-mail(s) zhujack@mail.nih.gov
Phone (240)760-7439
Organization name NCI
Department Genetics Branch, Center for Cancer Research
Lab Dr. Paul Meltzer's Lab
Street address 9000 Rockville Pike
City Bethesda
State/province MD
ZIP/Postal code 20892
Country USA
 
Platforms (2)
GPL6104 Illumina humanRef-8 v2.0 expression beadchip
GPL13376 Illumina HumanWG-6 v2.0 expression beadchip
Samples (5)
GSM1214629 Chordoma xenograft sample 1
GSM1214630 Chordoma xenograft sample 2
GSM1214631 Chordoma sample 1
This SubSeries is part of SuperSeries:
GSE50137 A novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-kB signaling in chordoma biology
Relations
BioProject PRJNA216129

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE50135_RAW.tar 15.5 Mb (http)(custom) TAR
GSE50135_non_normalized.txt.gz 1.5 Mb (ftp)(http) TXT
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap